Clinical Trial Update: Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating an investigational drug for treating primary generalized tonic-clonic seizures in epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Investigational New Drug (unspecified)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy, Tonic-Clonic | Phase 4 | Status: COMPLETED